Vivani Medical
VANI
44 hedge funds and large institutions have $14M invested in Vivani Medical in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
35% more call options, than puts
Call options by funds: $42K | Put options by funds: $31K
16% more capital invested
Capital invested by funds: $12M → $14M (+$1.95M)
13% more funds holding
Funds holding: 39 → 44 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.45% → 0.46% (+0%)
Top Buyers
| 1 |
Millennium Management
New York
|
+$87.9K |
| 2 |
FC
Fore Capital
New York
|
+$67.3K |
| 3 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$55.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.3K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$49.1K |
Top Sellers
VANI Hedge Fund Activity: Q3 2018 in Review
44 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2018, worth a combined $14M — up 16% from $12M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VANI positions and 6 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $87.9K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $169K sold.
- 44 institutional investors held Vivani Medical (VANI) as of Q3 2018, up from 39 in Q2 2018.
- Funds reported $14M of Vivani Medical stock for Q3 2018, up 16% quarter-over-quarter.
- 11 funds opened new Vivani Medical positions in Q3 2018 and 6 closed out, a net change of +5 holders.
- The largest Vivani Medical buyer in Q3 2018 was Millennium Management, an estimated $87.9K added.
- The largest Vivani Medical seller in Q3 2018 was JP Morgan Chase, an estimated $169K sold.
Based on aggregated 13F filings for Q3 2018.